Biotech Co. Patents & Medical Device 5% Market Sha

IRVINE, California

Asking Price $4,000,000 Year Established
Annual Revenue Reason for Selling Seeking supportive capital partners to take to the next level.  
Annual P/L Attention Rick Carlson
Annual Cash Flow Listing Number 482917  
# of Employees Business Category Services: Medical, Dental

Business Overview:

The Company has proprietary technology that addresses a leading cause of maternal death (76,000) and fetal death (500,000) annually worldwide. 8% of pregnancies in the US and 14% worldwide have diagnoses that would be vastly improved by worldwide commercialization of the Company's proprietary device. A very low risk procedure that both provides quality of life improvement for the mother & baby and lowers health care costs is a win/win/win for all involved. Existing collaborations with major manufacturers coupled with a current expedited approval process with the FDA presents a tremendous opportunity for individuals or private equity groups seeking a transformative investment into a feel-good biotech story with exceptional legs and a vast runway with nearly unlimited upside. Able to work with groups/individuals in tranches of $500,000 to $1MM to advance into the pilot clinical study, $2-$3MM for the pivotal clinical study towards market approval in the US. They will seek direct sales with partnered hospitals, licensing / partnership deals could utlimately yield the balance of funding to fully deploy a commercial version of the technology. NDA is required for comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.

Property Features and Assets:

Market Competition and Expansion:

Competition: No current option available besides bed rest. Growth & Expansion: Huge market potential.

Additional Details:

  • The property is Leased.
  • The owner is willing to train/assist the new owner.
  • This is not homebased business opportunity.
  • This is not a franchise resale opportunity

Click to Print This Page